VYNE Therapeutics Inc (VYNE)

[jugs]

Adding at $1.62 today, taking advantage of a depressing market environment.

This is the perfect time to be adding MNLO shares given that we know it's responding to general stock market pressures despite no negative news from the company itself. An important investor consideration will always be market perceptions. With turmoil in numerous sectors of the market and the political arena, of course Menlo will react.

So I'm adding and looking gleefully towards end of year results. I've pretty much written off science coming up with a miracle cure, vaccine or therapy this year. With that acceptance comes renewed vigor as an investor with a long term focus and longer term goals.

I wish all here the very best!